Testing ways to assess pancreatic cyst risk and progression
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at patients who have been referred for evaluation of a pancreatic cyst. It aims to improve how doctors estimate risk and predict how cysts may change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were referred for assessment of a pancreatic cyst
- You can give informed consent (or have a consent process that works for you)
- You are not pregnant or breastfeeding
- You are not considered medically very high risk for procedures (ASA class 4 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study collects information from adults who have a pancreatic cyst (a fluid-filled sac in the pancreas). It may help doctors understand these cysts and how they change over time, which can improve future care.
This study looks at what features of certain pancreas and nearby tumors or cysts might help predict outcomes. It uses existing medical records (and consent, if applicable) and may help doctors better estimate prognosis for patients in the future.
This study builds a “molecular marker” lab model using pancreatic cyst fluid taken during planned pancreatic surgery. It aims to help tell which pancreatic cystic tumors are which, based on fluid analysis.
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
This study looks for molecular (lab) signals that may show advanced or higher-risk changes in certain pancreatic cysts. It may help doctors better sort which cysts are more concerning and may need closer attention.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.